Anti-IL-11 antibodies in mice and a report of longer lifespan
A social media report describes mice treated with anti-IL-11 antibodies living 20% to 25% longer. The source is an animal study, with no indication of the same effect in people.
Source: Anti-IL-11 antibodies in mice reported to extend lifespan (x.com). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
The report describes a study in mice in which animals treated with anti-IL-11 antibodies stayed healthy for longer and lived 20% to 25% longer. The result comes from animal research, not from testing in people.
Interleukin 11 (IL-11) is an immune system protein linked to inflammation and to aging processes. Animal research on aging often guides future studies, but these results do not show whether the effect would occur in humans. The findings still need to be confirmed by other studies, and safety must be assessed before any conclusion about human health can be drawn.
What it means
The finding suggests IL-11 may influence aging in mice. It is not yet known whether this applies to people, or what the long-term effects would be.
How to read it with care
Treat this report as a research lead, not as proof. It does not replace a medical consultation; anyone considering a change in diet, supplements or treatment should talk to a doctor or another qualified health professional.